gebhart/patrepeval huggingface dataset:
Power Load Event Detection and Classification Based on Edge Symbol Analysis and Support Vector Machine (2012)

Energy signature analysis of power appliance is the core of nonintrusive load monitoring (NILM) where the detailed data of the appliances used in houses are obtained by analyzing changes in the voltage and current. This paper focuses on developing an automatic power load event detection and appliance classification based on machine learning. In power load event detection, the paper presents a new transient detection algorithm. By turn-on and turn-off transient waveforms analysis, it can accurately detect the edge point when a device is switched on or switched off. The proposed load classification technique can identify different power appliances with improved recognition accuracy and computational speed. The load classification method is composed of two processes including frequency feature analysis and support vector machine. The experimental results indicated that the incorporation of the new edge detection and turn-on and turn-off transient signature analysis into NILM revealed more information than traditional NILM methods. The load classification method has achieved more than ninety percent recognition rate.
Optical Constants of ZnO (1997)

The complex dielectric functions, ε ( E )= ε 1 ( E )+ i ε 2 ( E ), of ZnO have been measured by spectroscopic ellipsometry (SE) in the photon-energy range between 1.5 and 5.0 eV at room temperature. The SE measurements are carried out on the surface parallel to the optic axis c , which allows the determination of the optical constants for light polarized perpendicular ( E ⊥ c ) and parallel to the c -axis ( E // c ). The measured SE spectra show the exciton peaks at ∼3.4 eV ( E 0 edge). These ε ( E ) spectra are analyzed on the basis of a simplified model of the interband transitions. Excellent agreement is achieved between the calculated and experimental results over the entire range of photon energies. Dielectric-function-related optical constants, such as the complex refractive index n * ( E )= n ( E )+ i k ( E ), absorption coefficient α( E ) and normal-incidence reflectivity R ( E ), of ZnO have also been reported.
Action of far-ultraviolet light on organic polymer films: applications to semiconductor technology (1983)

The late Ludvík Hoberlandt left several specimens of African Aradidae (Hemiptera: Heteroptera) in the collection of the National Museum in Prague which were labelled as new synonyms or types of new species, but, however, the corresponding taxonomic acts and decisions have never been published. As a result of their examination, Hoberlandt's 'Aradus africanus n. sp.' is identified as A. gracilipes Linnavuori, 1978, 'A. nuristanicus n. sp.' as A. betulae (Linnaeus, 1758), and 'Aradus intermedius n. sp.' is recognized as a new species, described here as A. congoensis sp. nov. (from the Democratic Republic of the Congo). Mezira lindemannae Kormilev, 1974, syn. nov., is synonymized with Brachyrhynchus abyssinicus Bergroth, 1895. The generic placement of Mezira amplicollis Linnavuori, 1978 in Brachyrhynchus Laporte, 1832 is confirmed. The status of 'Carventus machadoi n. sp.' (member of Burgeonia Schouteden, 1919; Angola) and 'Neuroctenus arnoldi n. sp.' (Zimbabwe), two additional putatively new species recognized by Hoberlandt, remains unresolved, pending the revision of the respective genera. The following new distributional records are given: Aradus gracilipes from Chad, Aradus betulae from Afghanistan, and Brachyrhynchus abyssinicus from Democratic Republic of the Congo, Guinea and Kenya.
Translocation of proteins across membranes: the signal hypothesis and beyond. (1979)

Proteins are translocated across membranes either coupled to translation (co-translationally) or after translation (post-translationally). The information for both modes of translocation is encoded in the protein in the form of a short-lived sequence extension (signal sequence). Additional information resides in the ribosome in the case of co-translational translocation, which proceeds via a ribosome--membrane junction. Translocation is mediated by specific receptors (ribosome and/or signal receptors) which are restricted in their location to distinct cellular membranes. In most cases the signal sequence is removed by a signal peptidase operating in an endoproteolytic mode. Membranes endowed with receptors for co-translational translocation are: the rough endoplasmic reticulum (RER) including the outer nuclear envelope membrane, the inner mitochondrial membrane and the thylakoid membrane of chloroplasts, in eukaryotic cells; and the plasma membrane in prokaryotic cells. Each of these membranes presumably contains a single distinctive signal receptor, ribosome receptor and signal peptidase. Membranes endowed with one distinct receptor each for post-translational translocation are both mitochondrial membranes, the chloroplast envelope membrane and the peroxisomal membrane. A signal sequence for co-translational translocation across the RER membrane that is identical in its secondary structure is shared by secretory, lysosomal and certain bitopic integral membrane proteins. Some integral membrane proteins presumably share another common sequence--referred to as stop-transfer sequence--which serves to interrupt translocation and thereby to orient the polypeptide chain in the lipid bilayer. Furthermore, the existence of a few specific 'sorting' sequences is postulated. These would be common to many proteins and would serve to route them to their final destination following translocation across or orientation within the membrane. Thus, the topological information which determines the intracellular pathway and the final location of a great number of proteins appears to reside in a small repertoire of specific sequences which are either a transient or a permanent part of the protein.
Microneedle-Mediated Allergen-Specific Immunotherapy for the Treatment of Airway Allergy in Mice (2020)

Subcutaneous allergen-specific immunotherapy (SCIT) qualifies as a promising approach for the permanent cure of IgE-mediated airway allergies, which can often manifest into allergic rhinitis and other allergic respiratory diseases. SCIT entails repeated administration of a high allergen dose into the subcutaneous (sc) region using a hypodermic needle for many (3-5) years, which is inconvenient and painful and reduces patient compliance. To overcome these limitations, we hypothesized that microneedles (MNs), which are minimally invasive and painless, could provide a novel approach for allergen desensitization by depositing the allergen into the superficial layers of the skin. To test this hypothesis, we compared MNs and SCIT for allergen desensitization in a mouse model of ovalbumin (Ova)-induced airway allergy. Mice were first made allergic to Ova and then treated with MNs coated with Ova (with or without CpG as an adjuvant) or via SCIT-Ova + alum (subcutaneous Ova + alum injections) for comparison. Treatment with coated MNs significantly induced Ova-specific serum IgG antibodies in a manner comparable to SCIT-Ova + alum-treated group. To test the efficacy against allergen challenge, treated mice were challenged with Ova via the nasal route. Coated MNs with Ova and CpG (MN-Ova + CpG) considerably suppressed the airway inflammation in allergic mice, evidenced by downregulation of proinflammatory cytokines (IL-5 and IL-13), upregulation of anti-inflammatory cytokine IL-10, and activation of Ova-specific immune response in bronchoalveolar (BAL) fluid. The therapeutic capacity of MN-based allergy treatment was further validated by the reduction in eosinophil and mast cell infiltration in the lung tissues of mice treated with MN-Ova + CpG, and low deposition of mucus inside their lung bronchioles. Overall, coated MNs ameliorated the symptoms of airway allergy in mice similar to SCIT and could provide a novel means of painless allergen-specific immunotherapy.
Sequence determinants of thermodynamic stability in a WW domain—An all‐β‐sheet protein (2009)

The stabilities of 66 sequence variants of the human Pin1 WW domain have been determined by equilibrium thermal denaturation experiments. All 34 residues composing the hPin1 WW three-stranded beta-sheet structure could be replaced one at a time with at least one different natural or non-natural amino acid residue without leading to an unfolded protein. Alanine substitutions at only four positions within the hPin1 WW domain lead to a partially or completely unfolded protein-in the absence of a physiological ligand. The side chains of these four residues form a conserved, partially solvent-inaccessible, continuous hydrophobic minicore comprising the N- and C-termini. Ala mutations at five other residues, three of which constitute the ligand binding patch on the concave side of the beta-sheet, significantly destabilize the hPin1 WW domain without leading to an unfolded protein. The remaining mutations affect protein stability only slightly, suggesting that only a small subset of side chain interactions within the hPin1 WW domain are mandatory for acquiring and maintaining a stable, cooperatively folded beta-sheet structure.
Cationic Molybdenum Imido Alkylidene Complexes (2008)

Addition of 1 equiv of [HNMe2Ph]BArF4 (ArF = 3,5-(CF3)2C6H3) to Mo(NAr)(CHCMe2Ph)(Pyrrolide)2 (Pyrrolide = parent pyrrolide (Pyr) or 2,5-dimethylpyrrolide (Me2Pyr)) species in THF produced [Mo(NAr)(CHCMe2Ph)(Pyrrolide)(THF)x]BArF4 species (x = 2 for Me2Pyr (1b) or 3 (1a) for Pyr; Ar = 2,6-diisopropylphenyl). [Mo(NAr)(CHCMe2Ph)(Me2Pyr)(2,4-lutidine)]BArF4 (1c) was formed upon addition of 2,4-lutidine to [Mo(NAr)(CHCMe2Ph)(Me2Pyr)(THF)2]BArF4 (1b). Addition of 1 equiv of hexafluoro-tert-butanol to 1a produced {Mo(NAr)(CHCMe2Ph)[OC(CF3)2Me](THF)3}BArF4 (3a), while {Mo(NAr)(CHCMe2Ph)[OCMe(CF3)2](THF)2}BArF4 (3b) was obtained similarly through addition of hexafluoro-tert-butanol to 1b. Similar reactions produced unstable [Mo(NAr)(CHCMe2Ph)(O-2,6-i-Pr2C6H3)(THF)]BArF4 (3c) and [Mo(NAr)(CHCMe2Ph)(OAdamantyl)(THF)2]BArF4 (3d). Treatment of 1b with 2 equiv of 2,6-diisopropylphenol yielded [Mo(NAr)(CH2CMe2Ph)(O-2,6-i-Pr2C6H3)2]BArF4 (4). Compound 3a reacts with ethylene to yield {Mo(NAr)(CH2CH2)[OC(CF3)2Me](THF)3}BArF4 (6). The reaction between Mo(NAr)(CHCMe2Ph)(OTf)2(dme) and 2 equiv of Li(MesPyr) (MesPyr = 2-mesitylpyrrolide) gave Mo(NAr)(CHCMe2Ph)(MesPyr)2 (2), but no cationic species could be prepared that contain 2-mesitylpyrrolide. Compounds 1a, 1c, 2, 3a, 4, and 6 were characterized crystallographically.
Left atrial appendage: structure, function, and role in thromboembolism (1999)

The left atrial appendage (LAA) is derived from the left wall of the primary atrium, which forms during the fourth week of embryonic development. It has developmental, ultrastructural, and physiological characteristics distinct from the left atrium proper. The LAA lies within the confines of the pericardium in close relation to the free wall of the left ventricle and thus its emptying and filling may be significantly affected by left ventricular function. The physiological properties and anatomical relations of the LAA render it ideally suited to function as a decompression chamber during left ventricular systole and during other periods when left atrial pressure is high. These properties include the position of the LAA high in the body of the left atrium; the increased distensibility of the LAA compared with the left atrium proper; the high concentration of atrial natriuretic factor (ANF) granules contained within the LAA; and the neuronal configuration of the LAA. Thrombus has a predilection to form in the LAA in patients with atrial fibrillation, mitral valve disease, and other conditions. The pathogenesis has not been fully elucidated; however, relative stasis which occurs in the appendage owing to its shape and the trabeculations within it is thought to play a major role. Obliteration or amputation of the LAA may help to reduce the risk of thromboembolism, but this may result in undesirable physiological sequelae such as reduced atrial compliance and a reduced capacity for ANF secretion in response to pressure and volume overload.
Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling (2006)

The liver is known to be a classical immunoprivileged site with a relatively high resistance against immune responses. Here we demonstrate that highly activated liver-specific effector CD8+ T cells alone were not sufficient to trigger immune destruction of the liver in mice. Only additional innate immune signals orchestrated by TLR3 provoked liver damage. While TLR3 activation did not directly alter liver-specific CD8+ T cell function, it induced IFN-alpha and TNF-alpha release. These cytokines generated expression of the chemokine CXCL9 in the liver, thereby enhancing CD8+ T cell infiltration and liver disease in mice. Thus, nonspecific activation of innate immunity can drastically enhance susceptibility to immune destruction of a solid organ.
Reducing MOSFET 1/f noise and power consumption by switched biasing (2000)

Switched biasing is proposed as a technique for reducing the 1/f noise in MOSFET's. Conventional techniques, such as chopping or correlated double sampling, reduce the effect of 1/f noise in electronic circuits, whereas the switched biasing technique reduces the 1/f noise itself. Whereas noise reduction techniques generally lead to more power consumption, switched biasing can reduce the power consumption. It exploits an intriguing physical effect: cycling a MOS transistor from strong inversion to accumulation reduces its intrinsic 1/f noise. As the 1/f noise is reduced at its physical roots, high frequency circuits, in which 1/f noise is being upconverted, can also benefit. This is demonstrated by applying switched biasing in a 0.8 /spl mu/m CMOS sawtooth oscillator. By periodically switching off the bias currents, during time intervals that they are not contributing to the circuit operation, a reduction of the 1/f noise induced phase noise by more than 8 dB is achieved, while the power consumption is also reduced by 30%.
Effects of a sialoglycopeptide on early events associated with signal transduction (1991)

A sialoglycopeptide (SGP), isolated and purified from bovine cerebral cortex cells, was studied in regard to early signal transduction events associated with the cell cycle. Previously shown to be a potent antagonist to a variety of mitogens, the SGP abrogated the ability of 12-O-tetradecanoylphorbol-13 acetate (TPA) to elicit an alkalinization of 3T3 cell cytosol, but only when added minutes prior to, or simultaneously with, the tumor promoter. 3T3 cell TPA-mediated Ca2+ mobilization was also inhibited by the SGP although the inhibitor itself did not bind Ca2+ in a cell-free assay. The results are discussed in light of the already known kinetics of interaction between the SGP, various mitogens, and the calcium ionophore A23187 with regard to the pivotal events leading to the decision of a cell to divide or not to divide.
Further Studies on the Immunogenicity of Haemophilus influenzae Type b and Pneumococcal Type 6A Polysaccharide-Protein Conjugates (1983)

Conjugates were prepared by carbodiimide-mediated coupling of adipic acid hydrazide derivatives of Haemophilus influenzae type b (Hib), Escherichia coli K100, and pneumococcal 6A (Pn6A) polysaccharides with tetanus toxoid (TT), as an example of a "useful" carrier, and horseshoe crab hemocyanin (HCH), as an example of a "nonsense" carrier. These conjugates were injected into NIH mice, and their serum antibody responses to the polysaccharides and proteins were characterized. As originally reported, Hib conjugates increased the immunogenicity of the capsular polysaccharide and elicited greater than the estimated protective levels of anti-Hib antibodies in most recipients after one injection and in all after the third injection (Schneerson et al., J. Exp. Med. 152:361-376, 1980). Both Hib conjugates induced similar anti-Hib responses. The K100-HCH conjugate was more immunogenic than the K100-TT conjugate and elicited anti-Hib responses similar to the Hib conjugates after the third injection. Simultaneous injection of the K100 and the Hib conjugates did not enhance the anti-Hib response. The Pn6A-TT conjugate induced low levels of anti-Hib antibodies; when injected simultaneously with the Hib conjugates, the anti-Hib response was enhanced, as all mice responded after the first injection and with higher levels of anti-Hib than observed with the Hib conjugates alone (P < 0.05). The Pn6A conjugates were not as immunogenic as the Hib conjugates. Pn6A-TT was more effective than was Pn6A-HCH; it elicited anti-Pn6A (>100 ng of antibody nitrogen per ml) in 6 of 10 mice after the third injection. The addition of the Hib-HCH conjugate to the Pn6A-TT conjugate increased the anti-Pn6A response with a higher geometric mean antibody titer, and 9 of 10 mice responded after the third injection. A preparation of diphtheria toxoid, TT, and pertussis vaccine increased the anti-Hib antibody levels after the first injection only in mice receiving Hib-TT, but not in mice receiving Hib-HCH, suggesting that additional carrier protein (TT) enhanced the anti-polysaccharide response. Simultaneous injection of Hib and Pn6A conjugates with the same or different carriers resulted in an enhanced serum antibody response to each polysaccharide. The anti-tetanus toxin response reached protective levels (>0.01 U/ml) in most mice after the first injection and in all mice after the second and third injections of TT conjugates. A progressive increase in the anti-HCH response with each additional injection was noted in animals receiving HCH conjugates. Animals receiving the diphtheria toxoid-TT-pertussis vaccine preparation responded with a greater increase in anti-carrier antibody than those receiving the conjugates alone. This method of synthesis provided conjugates capable of inducing protective levels of antibodies to both the polysaccharides and carrier proteins.
Radioimmunoassay of arginine vasopressin in human plasma and urine, a resin microcolumn method. (1980)

A new method was developed for the estimation of arginine vasopressin (AVP) in plasma and urine. Samples were extracted by a microcolumn of resin and assayed radioimmunologically using a highly sensitive antiserum to AVP. Ion-exchange resin, CG-50, H+ form, packed in a small column (diameter 4 mm, height 6 mm), was proved effective to remove the interfering substances and to concentrate the AVP in the sample. The application of 80% acid acetone successive to diluted HCl brought about a consistent recovery of AVP from the resin column. Recoveries were 66.4 +/- 8.5% for plasma and 85.4 +/- 9.7% for urine. In normal subjects plasma AVP levels were 3.9 +/ 0.3 pg/ml (mean +/- S.D.) in ambulatory states, 4.9 +/- ).6 after overnight fast, and 0.4 +/- 0.2 after water lading. High levels of 2.0 +/- 24.2 pg/ml were obtained in patinents with syndrome of inappropriate secretion of ADH (SIADH), low values of 0-1.8 pg/ml in diabetes inipidus. Urinary excretions of AVP were 117.4 +/- 59.4 ng/24/hr (mean +/- S.D.) in normal controls, 191 +/- 177.0/24 hr in SIADH, and 17.0 +/- 12.0/24 hr in diabetes insipidus.
DNA Inoculation Induces Cross Clade Anti‐HIV‐1 Responses (1995)

Nucleic acid or DNA immunization represents a novel approach to vaccine and immune therapeutic development. The direct injection of expression cassettes into a living host results in in vivo gene expression and immune activation. In the case of HIV-1 it has been shown by our laboratory that facilitated injection mimicks aspects of live attenuated vaccines and that both humoral and cellular responses can be induced upon injection of a nucleic acid sequence directly into a host target tissue. Antisera from HIV-1 plasmid expression cassette-immunized animals contain anti-HIV envelope glycoprotein immune responses. The antiserum neutralizes HIV-1 infection and inhibits cell to cell infection in vitro. Cellular immune responses have also been evaluated. We observed both T cell proliferation and isotype switching consistent with the production of relevant T helper immune responses in immunized animals. Furthermore it was demonstrated that CTL lysis of relevant env-expressing targets was similarly induced. These studies further define the importance of evaluating this new technology for vaccine and immune therapeutic development for HIV-1 as well as for other human viral pathogens.
The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception (2015)

In this article, we show that in young reproductive-age women most vulnerable to HIV, hormonal contraceptives are associated with altered cervical immunity in a manner dependent on the presence of genital tract infections. Through altered immunity, hormones may predispose women to bacterial and viral pathogens; conversely, a preexisting specific infection or disturbed vaginal microbiota may suppress the immune activation by levonorgestrel or exacerbate the suppressed immunity by DMPA, thus increasing HIV risk by their cumulative action. Clinical studies assessing the effects of contraception on HIV susceptibility and mucosal immunity may generate disparate results in populations that differ by microbiota background or prevalence of undiagnosed genital tract infections. A high prevalence of asymptomatic infections among HC users that remain undiagnosed and untreated raises even more concerns in light of their combined effects on biomarkers of HIV risk. The molecular mechanisms of the vaginal microbiome's simultaneous interactions with hormones and HIV remain to be elucidated.
Lack of intermediate‐affinity interleukin‐2 receptor in mice leads to dependence on interleukin‐2 receptor α, β and γ chain expression for T cell growth (1996)

An interleukin (IL)-4 dependent mouse T cell clone 8.2 derived from an IL-2-dependent T cell line was characterized. As measured by flow cytometric analysis and Northern blotting, it expresses IL-2 receptor beta (IL-2R beta) and gamma (IL-2R gamma) chains, but has lost expression of IL-2 receptor alpha chain (IL-2R alpha). To investigate the properties of the mouse IL-2R beta gamma complex and the role of IL-2R alpha gene expression, this clone was further studied. T cell clone 8.2 has lost the capacity to bind 125I-labeled human IL-2 under experimental conditions able to detect intermediate-affinity IL-2R in human cells. Mouse IL-2 is unable to block the binding of mAb TM beta 1 to 8.2 cells. Under the same experimental conditions, mouse IL-2 blocks the binding of TM beta 1 to C30-1 cells expressing the IL-2 alpha beta gamma complex. Since TM beta 1 recognizes an epitope related to the IL-2 binding site of IL-2R beta, these results can be taken as a demonstration that mouse IL-2R beta gamma does not bind mouse IL-2. Furthermore, T cell clone 8.2 does not proliferate in response to recombinant mouse or human IL-2. On the other hand, T cell transfectant lines expressing heterospecific receptors made of the human IL-2R beta and mouse IL-2R gamma chains bind 125I-labeled human IL-2 and proliferate in response to IL-2. This establishes the difference between mouse and human IL-2R beta chains. Transfection of T cell clone 8.2 with human IL-2R alpha genes restores their capacity to proliferate in response to IL-2. In addition, all transfectants grown in IL-2 express the endogeneous mouse IL-2R alpha chain. When grown in IL-4, the endogeneous mouse IL-2R alpha gene remains silent in all these transfectants. These results show that, contrary to the human, the mouse does not express an intermediate-affinity IL-2R. Expression of the IL-2R alpha gene is therefore required for the formation of the functional IL-2R in mice.